Shanghai Labway Clinical Laboratory Co., Ltd Share Price
Equities
301060
CNE100004RG8
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.77 CNY | -0.20% | +8.19% | -26.49% |
Sales 2022 | 4.2B 580M 46.41B | Sales 2023 | 1.67B 231M 18.51B | Capitalization | 5.32B 735M 58.83B |
---|---|---|---|---|---|
Net income 2022 | 617M 85.15M 6.82B | Net income 2023 | -142M -19.6M -1.57B | EV / Sales 2022 | 1.77 x |
Net cash position 2022 | 421M 58.13M 4.66B | Net cash position 2023 * | - 0 0 | EV / Sales 2023 | 3.18 x |
P/E ratio 2022 |
12.7
x | P/E ratio 2023 |
-37.6
x | Employees | 1,878 |
Yield 2022 |
1.53% | Yield 2023 |
-
| Free-Float | 32.29% |
1 day | -0.20% | ||
1 week | +8.19% | ||
Current month | -18.24% | ||
1 month | -15.85% | ||
3 months | -13.54% | ||
6 months | -26.93% | ||
Current year | -26.49% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 19/08/15 |
Xi Gu Wang
DFI | Director of Finance/CFO | 54 | 21/07/22 |
Zhi Sen Mao
BRD | Director/Board Member | 64 | 16/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lei Wang
BRD | Director/Board Member | 42 | 16/12/21 |
Wei Xiong Zeng
CEO | Chief Executive Officer | 56 | 19/08/15 |
Hui Juan Jing
BRD | Director/Board Member | 53 | 19/08/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 12 M€ | -16.71% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 9.77 | -0.20% | 5,898,500 |
25/04/24 | 9.79 | +1.14% | 5,012,100 |
24/04/24 | 9.68 | +2.65% | 6,221,600 |
23/04/24 | 9.43 | +3.63% | 6,003,200 |
22/04/24 | 9.1 | +0.78% | 4,534,926 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-26.49% | 540M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- 301060 Stock